Notably, the APOE-ε3 V236E Jacksonville variant (APOE3-Jac) reduces fibrillar Aβ plaques, whereas the APOE3 R136S Christchurch (APOE3ch) reduces cognitive decline in patients with an autosomal AD mutation [23]. This evidence concerns the gene APOE and Alzheimer disease.